The results showed country-specific challenges, such as elevated OTA in southern Europe and FUM across Latin America and ...

Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...

Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has ...

An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

New biomarkers enhance multiple sclerosis (MS) diagnosis, enabling earlier detection and improved patient care, transforming ...